Chemotherapy-Grade Nitrile Gloves: ASTM D6978, Permeation Testing, and Safe Handling for Canadian Pharmacies

Quick Summary: If your pharmacy, oncology clinic, or veterinary oncology team handles hazardous drugs, standard examination gloves are not enough. Chemotherapy-grade nitrile gloves are tested against ASTM D6978 — a standard that measures how long a glove resists permeation by 27 chemotherapy drugs. This guide explains what ASTM D6978 actually tests, why 4.0 mil nitrile is the practical benchmark for compounding and administration, how Canadian regulations (Health Canada, provincial occupational health rules) treat hazardous drug handling, and what a procurement manager should verify before buying. Read time: 7 minutes.

1. Why Chemotherapy-Grade Gloves Are a Different Product Category

There is a persistent myth in medical supply procurement: "nitrile is nitrile, so any nitrile glove protects against hazardous drugs." That assumption is dangerous and, in a Canadian regulatory context, hard to defend.

Standard examination gloves are manufactured and tested for barrier performance against microorganisms and, in the case of ASTM D6319, for tensile strength, dimensions, and freedom from holes. They are not tested for chemical permeation. A chemotherapy drug like cyclophosphamide or paclitaxel is a small molecule dissolved in a carrier — given enough contact time, it can migrate through an untested polymer film at rates that matter for occupational exposure.

That is where the distinction lands: a chemotherapy-grade glove is a glove that has been put through a permeation challenge with a defined panel of antineoplastic drugs, under controlled conditions, and demonstrated breakthrough times and permeation rates below specified thresholds. The test protocol used in North America is ASTM D6978. For Canadian facilities looking at this category, the Aurelia Protégé 4.0 mil chemotherapy-grade nitrile glove is an example of a product positioned specifically for hazardous drug handling.

For a Canadian buyer, the practical takeaway is simple. If staff compound or administer hazardous drugs — even occasionally — the glove spec on your purchase order should say "ASTM D6978 tested," not just "nitrile examination glove."

2. ASTM D6978: What the Standard Actually Measures

ASTM D6978, formally Standard Practice for Assessment of Resistance of Medical Gloves to Permeation by Chemotherapy Drugs, is not a single-pass/fail test. It measures two things:

• Breakthrough time — how long the drug takes to first appear on the inner surface of the glove material
• Permeation rate — how quickly the drug moves through the material after breakthrough

The test uses a permeation cell where a challenge drug is placed on the outside of a glove sample and a collection medium on the inside, then analyzes the collection medium over time. Because glove thickness varies by fingertip and web space, the standard requires testing samples from multiple locations on the glove, not just the palm. That sampling requirement matters — thin spots are where permeation starts.

The most commonly cited performance threshold for chemotherapy gloves is a permeation rate below 0.01 µg/cm²/min, which is the value referenced in the published literature and by testing laboratories for gloves used in chemotherapy handling. Gloves that meet this threshold with a full drug panel are typically labeled "chemo-tested" or "chemotherapy grade."

One peer-reviewed study measured permeation of 27 chemotherapy drugs through 15 surgical and examination gloves after simulated dynamic testing and found substantial variation between glove types and manufacturers — reinforcing why buyers should not assume equivalence between products that merely look similar. The study's authors noted that glove selection based on actual permeation data, rather than brand reputation, is the defensible procurement approach.

3. The Drug Panel: What "27 Drugs" Means in Practice

When a glove manufacturer claims ASTM D6978 compliance, the credibility of that claim depends on the drug panel tested. Common antineoplastic drugs included in permeation panels are:

A glove tested against a 27-drug panel covering these classes gives a pharmacy team a defensible baseline. A glove tested against two or three drugs does not. When reviewing a supplier's technical data sheet, ask for the drug list and the breakthrough time for the drugs your facility actually compounds — if your oncology clinic mainly infuses taxanes and platinum compounds, those specific results matter more than the overall claim.

4. Permeation vs. Puncture: Two Different Failure Modes

Procurement teams often confuse two very different glove failure modes:

Both matter in a compounding pharmacy, but they require different product decisions. A thicker glove (5.0 or 6.0 mil) generally improves puncture resistance, but thickness alone does not guarantee low permeation — the polymer formulation and the drug's solubility in that formulation drive permeation. Some 6.0 mil gloves perform well for puncture but are not chemo-tested. Conversely, a 4.0 mil chemo-tested nitrile glove can outperform a thicker untested glove for hazardous drug work. For routine examination tasks that do not involve hazardous drugs, a standard CliniEco 4 mil nitrile examination glove covers most patient-contact scenarios at a lower cost per glove.

This is why the procurement spec should separate the two requirements: chemotherapy compounding gloves (ASTM D6978 tested) for hazardous drug tasks, and general examination gloves (ASTM D6319 compliant) for routine patient contact. Trying to buy one glove for both roles usually compromises one of the two.

5. Canadian Regulatory Context: What Health Canada and Provinces Expect

Canada regulates hazardous drug handling through a layered system. There is no single national "chemo glove law," but the practical obligations come from several places:

• Health Canada regulates medical gloves as medical devices under the Medical Devices Regulations (SOR/98-282). Gloves sold as chemotherapy-grade should be licensed appropriately for their claims; a buyer should be able to verify the device licence or establishment listing.
• Provincial occupational health and safety rules — for example, Ontario's Regulation 379/06 (Designated Substances) and the general duty clauses of the Occupational Health and Safety Act — require employers to protect workers from hazardous biological and chemical agents, which extends to antineoplastic drugs.
• CSA standards (Canadian Standards Association) provide guidance on safe handling of hazardous drugs in healthcare settings, and facilities pursuing accreditation typically align their PPE selection with those guidelines.

The practical implication for procurement: keep documentation. If a worker is exposed to a hazardous drug and a question arises about PPE adequacy, the glove purchase record — showing ASTM D6978 tested product, lot numbers, and expiry — becomes part of the employer's due diligence. Buyers should request lot-specific certificates of analysis or at minimum confirm the manufacturer's D6978 test report covers the drugs the facility uses.

6. Canadian Data on Contamination: Why This Is Not Theoretical

A 2026 study of antineoplastic drug contamination in Canadian healthcare centres found measurable surface contamination on work surfaces and, in some cases, on PPE in settings where hazardous drugs are handled. The authors called for continued emphasis on safe handling practices, including appropriate glove use, closed-system transfer devices, and environmental monitoring. The finding echoes international literature: even with precautions, contamination occurs, and gloves are a frontline control.

Another published study examined fentanyl and carfentanil permeation through commercial disposable gloves and found that not all gloves provide the same protection — again underscoring that glove selection should be driven by permeation data for the specific substances handled.

For a Canadian pharmacy or clinic, this data changes the conversation from "are we compliant on paper" to "are our gloves actually doing the job." Surface contamination studies are a reminder that the weakest link is often the product nobody verified.

7. What a Procurement Manager Should Verify Before Buying

Here is a practical checklist to use the next time you evaluate chemotherapy-grade glove suppliers:

1. Ask for the ASTM D6978 test report — not a marketing page. Confirm the drug panel includes the drugs your facility compounds.
2. Check breakthrough time — the report should state breakthrough times; a longer breakthrough time is better for compounding tasks.
3. Verify the medical device status — confirm the product is licensed or listed in Canada for its intended use.
4. Confirm powder-free — powder can contaminate sterile compounding environments; powder-free is the standard for pharmacy use.
5. Check sizing and texture — staff compliance drops when gloves are uncomfortable; textured fingers help with vial handling.
6. Review storage and expiry — like all medical gloves, chemotherapy-grade gloves degrade over time; check expiry dates on receipt.
7. Verify supply continuity — chemotherapy compounding cannot stop; confirm the supplier can maintain stock levels.

Facilities that standardize on a verified chemo-tested nitrile glove for hazardous drug tasks, and keep routine exam gloves for everything else, tend to have both better compliance and better cost control than facilities that try to overspend on one premium glove for all uses. For high-volume facilities that run a dedicated hazardous drug station plus general exam rooms, pairing a chemo-tested glove with a wholesale case of INTCO Touch Flex Advancare gloves for routine use keeps the overall programme affordable without compromising the high-risk tasks.

8. CliniEco's Approach to Hazardous Drug PPE

CliniEco supplies medical PPE to Canadian clinics, pharmacies, and veterinary practices. For hazardous drug handling, we carry the Aurelia Protégé nitrile examination glove — a 4.0 mil, powder-free, chemotherapy-grade option tested for permeation resistance — alongside our standard CliniEco 4 mil nitrile gloves for routine examination use, and INTCO Touch Flex Advancare cases for high-volume facilities.

We do not blur the line between the two categories. If a facility compounds hazardous drugs, we recommend the chemo-tested product for those tasks and the standard product for general patient contact — and we help buyers verify the documentation before they commit. For facilities going through a bulk procurement cycle, our wholesale case options (10-box cases) keep the per-glove cost predictable.

10. Final Word for Canadian Buyers

Chemotherapy-grade gloves are not a luxury add-on; they are a defined product category with a defined test method. The gap between "nitrile" and "ASTM D6978 tested nitrile" is the difference between assuming protection and verifying it. For facilities that handle hazardous drugs, that verification is a core part of occupational safety due diligence — and it is exactly the kind of detail a procurement manager should be able to defend in an audit.

If your team is reviewing hazardous drug PPE and wants help comparing chemo-tested options, bulk pricing, or documentation, CliniEco's team can walk through the product data with you. For bulk or wholesale inquiries on chemotherapy-grade gloves and other medical PPE, contact our sales team — we support Canadian pharmacies, oncology clinics, and veterinary practices with consistent supply and verified documentation.

References

1. ASTM International. ASTM D6978 — Standard Practice for Assessment of Resistance of Medical Gloves to Permeation by Chemotherapy Drugs. https://www.astm.org/d6978-05.html
2. ASTM International. ASTM D6319 — Standard Specification for Nitrile Examination Gloves for Medical Application. https://www.astm.org/d6319-19.html
3. Permeation measurement of 27 chemotherapy drugs after simulated dynamic testing on surgical and examination gloves. PubMed PMID 32847481. https://pubmed.ncbi.nlm.nih.gov/32847481/
4. Fentanyl and carfentanil permeation through commercial disposable gloves. PubMed PMID 32658631. https://pubmed.ncbi.nlm.nih.gov/32658631/
5. Antineoplastic drug contamination and safe handling practices in Canadian healthcare centres. PubMed PMID 41591954. https://pubmed.ncbi.nlm.nih.gov/41591954/
6. Health Canada. Medical Devices Regulations (SOR/98-282). https://laws-lois.justice.gc.ca/eng/regulations/SOR-98-282/
7. Government of Ontario. Regulation 379/06 — Designated Substances. https://www.ontario.ca/laws/regulation/060379
8. Canadian Standards Association (CSA Group). Standards for healthcare facilities. https://www.csa.org/standards
9. World Health Organization. Hand hygiene in health care. https://www.who.int/teams/integrated-health-services/infection-prevention-control/hand-hygiene
10. World Health Organization. WHO Guidelines on Hand Hygiene in Health Care. https://www.who.int/publications/i/item/9789241597906
11. Health Care Without Harm. Safe handling of hazardous drugs. https://noharm.org/
12. CDC/NIOSH. Hazardous Drug Exposures in Health Care. https://www.cdc.gov/niosh/topics/hazdrug/default.html
13. Emerging Infectious Diseases (CDC). Journal archive. https://wwwnc.cdc.gov/eid/
14. Antimicrobial Resistance & Infection Control (Springer, open access). https://link.springer.com/journal/13756

Facilities handling hazardous drugs should also be able to show their sterilizer is monitored: a 5-pack biological indicator trial covers a month of daily testing.

Related Reading

• Specimen Bags: 95kPa Seal Standards Explained for Canadian Labs
• Are Nitrile Gloves Latex Free? What Canadian Buyers Should Know
• Nitrile Gloves for Lab Work: A Buyer's Guide for Canadian Laboratories

Frequently Asked Questions

Are all nitrile gloves chemotherapy-grade?

No. Standard nitrile examination gloves are tested to ASTM D6319 for physical properties and leak resistance, not for chemical permeation. Only gloves specifically tested to ASTM D6978 with a defined drug panel can be called chemotherapy-grade.

What thickness should chemotherapy gloves be?

4.0 mil is a common practical benchmark for compounding and administration gloves. Some facilities prefer 5.0 or 6.0 mil for added puncture resistance, but thickness does not guarantee low permeation — the polymer formulation matters more. Verify the D6978 report for the thickness you buy.

How often should chemotherapy gloves be changed?

Follow your facility's hazardous drug handling protocol. General guidance is to change gloves when visibly contaminated, after handling each patient or batch, and immediately if a spill occurs. Permeation is time-dependent, so extended wear increases risk.

Can chemotherapy gloves be reused?

No. Chemotherapy-grade gloves are single-use. Reuse increases the risk of both permeation and puncture. Dispose of them according to your facility's hazardous waste protocol.

Does Health Canada require ASTM D6978 testing?

Health Canada regulates gloves as medical devices, but the D6978 standard itself is a voluntary performance standard that manufacturers use to support claims. The regulatory expectation is that claims made about a device are substantiated — so a "chemo-grade" claim without D6978 testing would be difficult to defend.

Do veterinary oncology teams need chemotherapy-grade gloves?

Yes. Veterinary oncology staff compound and administer the same class of antineoplastic drugs, often with less engineering control than human hospitals. The same permeation risk applies.

What about double gloving for chemotherapy?

Double gloving is recommended in many hazardous drug handling guidelines because it provides a second barrier and allows outer glove removal on contamination. Both layers should be chemotherapy-grade or at least verified for the task.

Where can I find the ASTM D6978 test method?

The standard is published by ASTM International (astm.org) and is available for purchase. Testing laboratories also publish summaries of the method and typical thresholds, including the 0.01 µg/cm²/min permeation rate referenced in the literature.

This article is for general information and does not constitute medical or legal advice. Always follow your facility's hazardous drug handling protocol and applicable provincial regulations.

Last updated: September 2026. CliniEco Medical is a licensed medical device establishment (MDEL #35334).